Characteristic | Â | Overall survival* | Breast cancer-specific survival* | ||
---|---|---|---|---|---|
 |  | Model 1 | Model 2 | Model 1 | Model 2 |
 | Total No. | HR (95% CI∞) | HR (95% CI∞) | HR (95% CI∞) | HR (95% CI∞) |
Nativity | Â | Â | Â | Â | Â |
   US-born | 18,330 | Reference | Reference | Reference | Reference |
   Foreign-born | 19,365 | 0.93 (0.90-0.96) | 0.93 (0.90-0.97) | 0.94 (0.90-0.99) | 0.95 (0.90-1.00) |
Stage at diagnosis | Â | Â | Â | Â | Â |
   Local | 19,190 | Reference | Reference | Reference | Reference |
   Regional | 13,564 | 2.17 (2.08-2.27) | 2.18 (2.08-2.27) | 3.35 (3.15-3.56) | 3.35 (3.15-3.57) |
   Distant | 1,666 | 7.98 (7.42-8.58) | 7.99 (7.43-8.59) | 14.28 (13.05-15.62) | 14.30 (13.07-15.64) |
   Missing | 3,275 | 2.57(2.33-2.83) | 2.57 (2.33-2.83) | 4.32 (3.83-4.87) | 4.33 (3.84-4.88) |
Neighborhood SES** (quintiles) | Â | Â | Â | Â | Â |
   1 (lowest) | 11,001 | 1.42 (1.33-1.52) | †| 1.31 (1.20-1.43) | †|
   2 | 8,993 | 1.29 (1.20-1.38) |  | 1.19 (1.09-1.30) |  |
   3 | 7,481 | 1.20 (1.11-1.28) |  | 1.10 (1.01-1.21) |  |
   4 | 5,894 | 1.05 (0.98-1.13) |  | 0.99 (0.90-1.09) |  |
   5 (highest) | 4,326 | Reference |  | Reference |  |
Combined neighborhood SES and Hispanic enclave** |  | †|  | †|  |
   High SES, low enclave | 11,780 |  | Reference |  | Reference |
   High SES, high enclave | 5,921 |  | 1.07 (1.01-1.13) |  | 1.03 (0.96-1.11) |
   Low SES, low enclave | 2,498 |  | 1.29 (1.19-1.39) |  | 1.24 (1.12-1.37) |
   Low SES, high enclave | 17,496 |  | 1.26 (1.21-1.32) |  | 1.22 (1.15-1.29) |